Pharmafile Logo
Pharmafocus logo
Advanced Search
anne_whitaker

Synta appoints Sanofi president as chief executive

August 11, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Synta, anne whitaker

US biopharma firm Synta Pharmaceuticals has confirmed that Anne Whitaker is joining the company as president and chief executive. Whitaker …

Appointment
GSK China

GSK investigator jailed by Chinese police

August 8, 2014
Medical Communications, Research and Development, Sales and Marketing China, GSK, Peter Humprhey

A private investigator hired by GlaxoSmithKline to look into the secret recording of a sex tape of its China boss …

News
digital_marketing_1

Digital: bridging the gap between doctor, pharma and patient

August 8, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing digital, doctors, pm society, social media

Digital technology is moving on apace, but is the pharma industry keeping up and just what are the opportunities to …

Feature
Astellas logo

Cancer Research UK and Astellas announce partnership

August 8, 2014
Medical Communications, Research and Development, Sales and Marketing Astellas, CRUK, Canncer, Pancreatic cancer

Cancer Research UK and its commercial arm, Cancer Research Technology (CRT) have announced they are joining forces with Astellas in …

News
willem_baralt_quanta

Quanta appoints new chief financial officer

August 8, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Quanta Fluid Solutions, a developer of advanced haemodialysis systems has appointed Willem Baralt as its new chief financial officer. Baralt …

Appointment
GSK clouds

RBS chairman favoured as next GSK head

August 8, 2014
Medical Communications, Research and Development, Sales and Marketing China, GSK, RBS, Sir Christopher Gent

The Royal Bank of Scotland’s current head Sir Philip Hampton is the most likely candidate to take over as the …

News
Kadcyla packshot

Storm brewing over Roche cancer drug price

August 8, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, Haslam, Kadcyla, NICE, Roche, Yervoy, rejection

The Breakthrough Breast Cancer charity and England’s drug pricing watchdog NICE have both attacked Roche for not lowering the price …

News
richard_sloggett_mhp

Hanover appoints former MHP executive

August 7, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hanover, mhp

Med comms firm Hanover has appointed Richard Sloggett as its new associate director, poaching him from its rival MHP Health. …

Appointment
jun_kono_astellas

Astellas Pharma announces new senior hires

August 7, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas

Astellas Pharma EMEA, the European division of Astellas Pharma, has appointed Simon Dew to the position of chief strategy officer …

Appointment

Cerner acquires Siemens Health Services for $1.3bn

August 7, 2014
Medical Communications, Sales and Marketing Health IT, Siemens, imaging, mhealth

Cerner Corporation has signed a deal sealing its takeover of Siemens Health Services for $1.3 billion in cash. Cerner will …

News
Shire logo

AbbVie/Shire deal under threat from tax laws

August 7, 2014
Medical Communications, Sales and Marketing AbbVie, AstraZeneca, Pfizer, Shire, tax inversion

The £32 billion deal between AbbVie and Irish specialist biotech Shire could be under threat from new rules in the …

News
digital_cloud_computing_0

New app allows blood imaging from a smartphone

August 7, 2014
Medical Communications, Research and Development app, digital, smartphone

An IT research team has developed a new smartphone app that works in conjunction with a small lens add-on that …

News
PatientsLikeMe

Actelion becomes latest recruit to join PatientsLikeMe

August 6, 2014
Medical Communications, Research and Development, Sales and Marketing Actelion, PatientsLikeMe, digital

PatientsLikeMe and Actelion have come together in order to help create a new patient-reported outcomes tool for the rare form …

News

Liberation Communications promotes two

August 6, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Liberation Communications

Liberation Communications has made two promotions this August: Danielle Smith (right), has been promoted to account director whilst Vicky Smith …

Appointment
dr_salmaan_dalvi_precious_cells

Precious Cells Group appoints NHS stem cell expert

August 6, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Stem cells

Precious Cells Group, a UK-based provider of stem cell technologies including Biobanking services, has appointed Dr Salmaan Dalvi as its …

Appointment
Avastin

Roche gains new licence for blockbuster oncology drug

August 6, 2014
Research and Development, Sales and Marketing EC, Roche, avastin, ovarian cancer

Roche’s blockbuster cancer treatment Avastin now has a new European licence to treat women with a certain type of ovarian …

News
Pradaxa

Pradaxa ‘safe’ says Australian regulator

August 6, 2014
Research and Development, Sales and Marketing AF, Australia, BMJ, Pradaxa, stroke

Australia’s drug regulator says it will not be updating its safety advice for Boehringer’s Pradaxa despite mounting safety issues around …

News
Novartis HQ

Novartis must drop vaccine price, says UK govt

August 5, 2014
Medical Communications, Sales and Marketing Bexsero, Novartis, innoculation, meningococcal vaccine

Novartis will have to significantly lower the price of its meningococcal B vaccine if it wants a lucrative UK inoculation …

News
MabThera Roche

Blood cancer injection given green light

August 5, 2014
Research and Development, Sales and Marketing MabThera, Roche, follicular lymphoma and small lymphocytic lymphoma

Roche has launched a new injection formulation of its blood cancer drug MabThera (rituximab) to treat patients with follicular lymphoma, …

News

Gene silencing back on the books for Roche

August 5, 2014
Research and Development, Sales and Marketing RNA, Roche, Santaris, gene silencing

Roche will pay $450 million to acquire the RNA specialist firm Santaris Pharma in order to once again begin research …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026